BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1129271)

  • 1. Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527).
    Wasserman SI; Whitmer D; Geotzl EJ; Austen KF
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):301-6. PubMed ID: 1129271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a).
    Kay AB; Shin HS; Austen KF
    Immunology; 1973 Jun; 24(6):969-76. PubMed ID: 4123965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity.
    Goetzl EJ; Wasserman SI; Austen F
    Arch Pathol; 1975 Jan; 99(1):1-4. PubMed ID: 234219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An eosinophil leukocyte chemotactic factor of anaphylaxis.
    Kay AB; Stechschulte DJ; Austen KF
    J Exp Med; 1971 Mar; 133(3):602-19. PubMed ID: 4106805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis.
    Goetzl EJ; Austen KF
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4123-7. PubMed ID: 1060093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187.
    Czarnetzki BM; König W; Lichtenstein LM
    J Immunol; 1976 Jul; 117(1):229-34. PubMed ID: 778263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic reactivity of eosinophils obtained from bone marrow and peritoneal cavity of cyclophosphamide-treated, Toxocara canis-infected mice.
    Nawa Y; Owhashi M; Imai J; Abe T
    Int Arch Allergy Appl Immunol; 1986; 80(4):412-6. PubMed ID: 3733233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil chemotaxis of supernatants from cultured Hodgkin's lymph node cells.
    Kay AB; McVie JM; Stuart AE; Krajewski A; Turnbull LW
    J Clin Pathol; 1975 Jun; 28(6):502-5. PubMed ID: 1141453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural determinants of the eosinophil: chemotactic activity of the acidic tetrapeptides of eosinophil chemotactic factor of anaphylaxis.
    Goetzl EJ; Austen KF
    J Exp Med; 1976 Dec; 144(6):1424-37. PubMed ID: 1003098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.
    Goetzl EJ; Tashjian AH; Rubin RH; Austen KF
    J Clin Invest; 1978 Mar; 61(3):770-80. PubMed ID: 641154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge.
    Soter NA; Wasserman SI; Austen KF
    N Engl J Med; 1976 Mar; 294(13):687-90. PubMed ID: 55969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophils and mediators of anaphylaxis. Histamine and imidazole acetic acid as chemotactic agents for human eosinophil leucocytes.
    Immunology; 1976 Nov; 31(5):797-802. PubMed ID: 992712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes.
    Czarnetzki BM; König W; Lichtenstein LM
    Int Arch Allergy Appl Immunol; 1978; 56(5):398-408. PubMed ID: 344231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor.
    Capron M; Capron A; Goetzl EJ; Austen KF
    Nature; 1981 Jan; 289(5793):71-3. PubMed ID: 7453810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From eosinophil chemotactic factor of anaphylaxis to leukotriene B4--chemistry, biology and functional significance of eosinophil chemotactic leukotrienes in dermatology.
    Czarnetzki BM; Rosenbach T
    Dermatologica; 1989; 179 Suppl 1():54-9. PubMed ID: 2550288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediator release from basophil granulocytes in chronic myelogenous leukemia.
    Clark RA; Gallin JI; Kaplan AP
    J Allergy Clin Immunol; 1976 Dec; 58(6):623-34. PubMed ID: 62774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation.
    König W; Frickhofen N; Tesch H
    Immunology; 1979 Apr; 36(4):733-42. PubMed ID: 437847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil chemotactic factor of anaphylaxis (ECF-A): cellular origin, structure and function.
    Geotzl EJ; Austen KF
    Monogr Allergy; 1977; 12():189-97. PubMed ID: 335214
    [No Abstract]   [Full Text] [Related]  

  • 20. The mediation of tissue eosinophilia in hypersensitivity reactions. II. Separation of a delayed eosinophil chemotactic factor from macrophage chemotactic factors.
    Hirashima M; Honda M; Hayashi H
    Immunology; 1976 Aug; 31(2):263-71. PubMed ID: 955679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.